↓ Skip to main content

Dove Medical Press

Vildagliptin: a new oral treatment for type 2 diabetes mellitus

Overview of attention for article published in Vascular Health and Risk Management, December 2008
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter
1 X user
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
87 Mendeley
Title
Vildagliptin: a new oral treatment for type 2 diabetes mellitus
Published in
Vascular Health and Risk Management, December 2008
DOI 10.2147/vhrm.s3005
Pubmed ID
Authors

Chantal Mathieu, Evy Degrande

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Brazil 1 1%
Unknown 85 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 15%
Student > Bachelor 11 13%
Student > Ph. D. Student 9 10%
Student > Postgraduate 6 7%
Other 6 7%
Other 13 15%
Unknown 29 33%
Readers by discipline Count As %
Medicine and Dentistry 17 20%
Pharmacology, Toxicology and Pharmaceutical Science 12 14%
Agricultural and Biological Sciences 6 7%
Chemistry 4 5%
Biochemistry, Genetics and Molecular Biology 3 3%
Other 11 13%
Unknown 34 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2023.
All research outputs
#7,455,082
of 26,017,215 outputs
Outputs from Vascular Health and Risk Management
#244
of 815 outputs
Outputs of similar age
#45,083
of 184,068 outputs
Outputs of similar age from Vascular Health and Risk Management
#7
of 20 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 815 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 184,068 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.